Home > Financial Ratios > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for BAFNA PHARMACEUTICALS
Please provide your vote to see the results

BAFNA PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) -4.88-22.9339.0023.66644.34

What is the latest Core EBITDA Growth ratio of BAFNA PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of BAFNA PHARMACEUTICALS is -4.88 based on Mar2025 Standalone results.
Year Core EBITDA Growth
Mar2025-4.88
Mar2024-22.93
Mar202339.00
Mar202223.66
Mar2021644.34

How is Core EBITDA Growth of BAFNA PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2025 -4.88
Negative
Mar2024 -22.93
Negative
Mar2023 39
64.84
Mar2022 23.66
-96.33
Mar2021 644.34 -

Other Financial Ratios of BAFNA PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of BAFNA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS ₹289.5 Cr -8.2% -17.5% 60.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹401,541.0 Cr -3.6% -6.8% -5.6% Stock Analytics
DIVIS LABORATORIES ₹163,031.0 Cr -5.4% -2.4% 3.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹138,451.0 Cr 3.6% 8.5% 23.5% Stock Analytics
CIPLA ₹112,377.0 Cr -5.1% -7.1% -3.5% Stock Analytics
DR REDDYS LABORATORIES ₹97,355.5 Cr -4.1% -8.3% -12.1% Stock Analytics


BAFNA PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS

-8.2%

-17.5%

60.6%

SENSEX

-0.4%

-1.7%

9.1%


You may also like the below Video Courses